Description of Medical ServiceImmunohistochemistry (IHC) testing for identification of mismatch repair deficiency for eligibility to access dostarlimab on the PBS in patients with recurrent or advanced endometrial cancer.
Description of Medical ConditionPatients with recurrent or advanced endometrial cancer which are mismatch repair deficient, who have progressed following prior treatment.
Reason for ApplicationNew MBS item
Medical Service TypeCo-dependent technology
Previous Application Number/sNot Applicable
Application FormApplication Form (PDF 1360 KB)
Application Form (Word 298 KB)
Consultation SurveyConsultation Survey (PDF 584 KB)
Consultation Survey (Word 68 KB)